Post-Myocardial Infarction Remodeling Prevention Therapy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.

Also called NCT01213251

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 129 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01213251
Other papers using this trial's data
  • Peri-infarct zone pacing to prevent adverse left ventricular remodelling in patients with large myocardial infarction European heart journal, 2016-02-01 DOI, PubMed 26321236

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Denmark, France, Germany, Hungary, Saudi Arabia, Slovakia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01213251. Randomized; triple masking; primary purpose prevention. Start 2010-12 (registry gives no type); primary completion 2015-10 (actual). Results posted on 2016-12-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-Myocardial Infarction Remodeling Prevention Therapy
Acronym
PRomPT
Condition
Acute Myocardial Infarction
Condition
Pacing Therapy
Condition
Cardiac Remodeling
Condition
Heart Failure
Intervention (Device)
Single Site Pacing
Intervention (Device)
Dual Site Pacing
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct01213251
Content hash
4414d4e3a6d60eea68929a8b320428314223ba41f2e0a4e7db6a7dcaf8def1d7